UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Doxil® — The first FDA-approved nano-drug: Lessons learned

Journal of controlled release, 2012-06, Vol.160 (2), p.117-134

Barenholz, Yechezkel (Chezy)

2012

Volltextzugriff (PDF)

Nanomedicines: addressing the scientific and regulatory gap

Annals of the New York Academy of Sciences, 2014-04, Vol.1313 (1), p.35-56

2014

Volltextzugriff (PDF)

In vitro experiments showing enhanced release of doxorubicin from Doxil® in the presence of ammonia may explain drug release at tumor site

Nanomedicine, 2015-10, Vol.11 (7), p.1841-1850

2015

Volltextzugriff (PDF)

Activation of complement by therapeutic liposomes and other lipid excipient-based therapeutic products: Prediction and prevention

Advanced drug delivery reviews, 2011-09, Vol.63 (12), p.1020-1030

2011

Volltextzugriff (PDF)

Roadmap and strategy for overcoming infusion reactions to nanomedicines

Nature nanotechnology, 2018-12, Vol.13 (12), p.1100-1108

2018

Volltextzugriff (PDF)

Immunorthodontics: in vivo gene expression of orthodontic tooth movement

Scientific reports, 2020-05, Vol.10 (1), p.8172-8172, Article 8172

2020

Volltextzugriff (PDF)

Liposome application : problems and prospects

Current opinion in colloid & interface science, 2001-02, Vol.6 (1), p.66-77

BARENHOLZ, Yechezkel

2001

Volltextzugriff (PDF)

Applying lessons learned from nanomedicines to understand rare hypersensitivity reactions to mRNA-based SARS-CoV-2 vaccines

Nature nanotechnology, 2022-04, Vol.17 (4), p.337-346

2022

Volltextzugriff (PDF)

Liposome drugs' loading efficiency: A working model based on loading conditions and drug's physicochemical properties

Journal of controlled release, 2009-10, Vol.139 (1), p.73-80

2009

Volltextzugriff (PDF)

Pseudo-anaphylaxis to Polyethylene Glycol (PEG)-Coated Liposomes: Roles of Anti-PEG IgM and Complement Activation in a Porcine Model of Human Infusion Reactions

ACS nano, 2019-08, Vol.13 (8), p.9315-9324

2019

Volltextzugriff (PDF)

Mechanisms and Barriers in Cancer Nanomedicine: Addressing Challenges, Looking for Solutions

ACS nano, 2017-01, Vol.11 (1), p.12-18

2017

Volltextzugriff (PDF)

Understanding the Role of Anti-PEG Antibodies in the Complement Activation by Doxil in Vitro

Molecules (Basel, Switzerland), 2018-07, Vol.23 (7), p.1700

2018

Volltextzugriff (PDF)

Optimization of vincristine–topotecan combination — Paving the way for improved chemotherapy regimens by nanoliposomes

Journal of controlled release, 2010-09, Vol.146 (3), p.326-333

2010

Volltextzugriff (PDF)

Sphingomyelin and cholesterol: from membrane biophysics and rafts to potential medical applications

Sub-cellular biochemistry, 2004, Vol.37, p.167

Barenholz, Yechezkel

2004

Volltextzugriff (PDF)

Synthesis and Characterization of Thiolate-Protected Gold Nanoparticles of Controlled Diameter

Journal of physical chemistry. C, 2019-11, Vol.123 (46), p.28486-28493

2019

Volltextzugriff (PDF)

Liposome-induced complement activation and related cardiopulmonary distress in pigs: factors promoting reactogenicity of Doxil and AmBisome

Nanomedicine, 2012-02, Vol.8 (2), p.176-184

2012

Volltextzugriff (PDF)

Interactions between Adsorbed Hydrogenated Soy Phosphatidylcholine (HSPC) Vesicles at Physiologically High Pressures and Salt Concentrations

Biophysical journal, 2011-05, Vol.100 (10), p.2403-2411

2011

Volltextzugriff (PDF)

Practical aspects in size and morphology characterization of drug-loaded nano-liposomes

International journal of pharmaceutics, 2018-08, Vol.547 (1-2), p.648-655

2018

Volltextzugriff (PDF)

Liposomes and other assemblies as drugs and nano-drugs: From basic and translational research to the clinics

Journal of controlled release, 2012-06, Vol.160 (2), p.115-116

2012

Volltextzugriff (PDF)

Therapeutic efficacy of combining pegylated liposomal doxorubicin and radiofrequency (RF) ablation: comparison between slow-drug-releasing, non-thermosensitive and fast-drug-releasing, thermosensitive nano-liposomes

PloS one, 2014-05, Vol.9 (5), p.e92555

2014

Volltextzugriff (PDF)

Prevention of infusion reactions to PEGylated liposomal doxorubicin via tachyphylaxis induction by placebo vesicles: A porcine model

Journal of controlled release, 2012-06, Vol.160 (2), p.382-387

2012

Volltextzugriff (PDF)

Liposomes, lipid biophysics, and sphingolipid research: from basic to translation research

Chemistry and physics of lipids, 2012-05, Vol.165 (4), p.363-364

2012

Volltextzugriff (PDF)

Resolvin D1 improves allograft osteointegration and directly enhances osteoblasts differentiation

Frontiers in immunology, 2023-02, Vol.14, p.1086930-1086930

2023

Volltextzugriff (PDF)

Nano-Drugs Based on Nano Sterically Stabilized Liposomes for the Treatment of Inflammatory Neurodegenerative Diseases

PloS one, 2015-07, Vol.10 (7), p.e0130442

2015

Volltextzugriff (PDF)

Quantitative Cryo-TEM Reveals New Structural Details of Doxil-Like PEGylated Liposomal Doxorubicin Formulation

Pharmaceutics, 2021-01, Vol.13 (1), p.123

2021

Volltextzugriff (PDF)

1 – 25 von 334

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(317)
Mit Volltextzugriff
(303)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(237)
Life Sciences & Biomedicine
(197)
Animals
(113)
Liposomes
(92)
Biochemistry & Molecular Biology
(88)
Biological And Medical Sciences
(82)
Humans
(82)
Pharmacology & Pharmacy
(66)
Chemistry
(58)
Mice
(58)
Physical Sciences
(58)
Medical Sciences
(54)
Biophysics
(53)
Chemistry, Multidisciplinary
(46)
Liposomes - Chemistry
(46)
Pharmacology. Drug Treatments
(43)
Female
(35)
Fundamental And Applied Biological Sciences. Psychology
(35)
Science & Technology - Other Topics
(31)
Male
(30)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Doxil® — The first FDA-approved nano-drug: Lessons learned

Nanomedicines: addressing the scientific and regulatory gap

In vitro experiments showing enhanced release of doxorubicin from Doxil® in the presence of ammonia may explain drug release at tumor site

Activation of complement by therapeutic liposomes and other lipid excipient-based therapeutic products: Prediction and prevention

Roadmap and strategy for overcoming infusion reactions to nanomedicines

Immunorthodontics: in vivo gene expression of orthodontic tooth movement

Liposome application : problems and prospects

Applying lessons learned from nanomedicines to understand rare hypersensitivity reactions to mRNA-based SARS-CoV-2 vaccines

Liposome drugs' loading efficiency: A working model based on loading conditions and drug's physicochemical properties

Pseudo-anaphylaxis to Polyethylene Glycol (PEG)-Coated Liposomes: Roles of Anti-PEG IgM and Complement Activation in a Porcine Model of Human Infusion Reactions

Mechanisms and Barriers in Cancer Nanomedicine: Addressing Challenges, Looking for Solutions

Understanding the Role of Anti-PEG Antibodies in the Complement Activation by Doxil in Vitro

Optimization of vincristine–topotecan combination — Paving the way for improved chemotherapy regimens by nanoliposomes

Sphingomyelin and cholesterol: from membrane biophysics and rafts to potential medical applications

Synthesis and Characterization of Thiolate-Protected Gold Nanoparticles of Controlled Diameter

Liposome-induced complement activation and related cardiopulmonary distress in pigs: factors promoting reactogenicity of Doxil and AmBisome

Interactions between Adsorbed Hydrogenated Soy Phosphatidylcholine (HSPC) Vesicles at Physiologically High Pressures and Salt Concentrations

Practical aspects in size and morphology characterization of drug-loaded nano-liposomes

Liposomes and other assemblies as drugs and nano-drugs: From basic and translational research to the clinics

Therapeutic efficacy of combining pegylated liposomal doxorubicin and radiofrequency (RF) ablation: comparison between slow-drug-releasing, non-thermosensitive and fast-drug-releasing, thermosensitive nano-liposomes

Prevention of infusion reactions to PEGylated liposomal doxorubicin via tachyphylaxis induction by placebo vesicles: A porcine model

Liposomes, lipid biophysics, and sphingolipid research: from basic to translation research

Resolvin D1 improves allograft osteointegration and directly enhances osteoblasts differentiation

Nano-Drugs Based on Nano Sterically Stabilized Liposomes for the Treatment of Inflammatory Neurodegenerative Diseases

Quantitative Cryo-TEM Reveals New Structural Details of Doxil-Like PEGylated Liposomal Doxorubicin Formulation

Suchergebnisse filtern